Medicine Description fosavance-uae 70 mg / 2800 iu
fosavance 70 mg tablets - rosheta uae is a medication that combines alendronate sodium, a bisphosphonate, with vitamin D3 (cholecalciferol). Alendronate acts by inhibiting osteoclast-mediated bone resorption, effectively slowing down the breakdown of bone tissue. This action leads to an increase in bone mass and strength, reducing the risk of fractures. The inclusion of vitamin D3 enhances calcium absorption from the gastrointestinal tract and helps maintain adequate serum calcium levels, which is crucial for healthy bone formation and maintenance. Together, these components work synergistically to promote better bone health and prevent osteoporosis-related complications.
Indications and Uses of fosavance 70 mg tablets - rosheta uae
- Treatment of osteoporosis, particularly in postmenopausal women
- Prevention of osteoporosis in individuals at risk
- Enhancement of bone density
- Reduction of fracture risk, especially in the hip and femur
Side Effects of fosavance 70 mg tablets - rosheta uae
- Gastrointestinal discomfort, such as nausea or abdominal pain
- Musculoskeletal pain
- Headaches
- Potential for esophageal irritation or ulceration
- Hypocalcemia, particularly if vitamin D levels are insufficient
Storage and Handling
Fosavance 70 mg tablets should be stored at room temperature, away from moisture and direct sunlight. Keep out of reach of children and do not use beyond the expiration date indicated on the package.
Patient Advice and Precautions
Patients should take Fosavance with a full glass of water upon waking, remaining upright for at least 30 minutes afterward to minimize esophageal irritation. It’s advisable to maintain adequate hydration and ensure an appropriate intake of calcium and vitamin D through diet or supplements as needed. Regular monitoring of bone density and overall bone health is important. Consult a healthcare professional before starting any new medications or supplements.